Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia-Reference-Cited by-同舟云学术

Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia

Published:2023-02 Issue: Volume:115 Page:109732
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Yang Zhongmei,Jia Xiaoyan,Deng Qinyin,Luo Mengdie,Hou Yan,Yue Jun,Mei Jie,Shan Nan^ORCID,Wu Zhao

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference36 articles.

1. Pre-eclampsia;Chappell;Lancet.,2021

2. Preeclampsia: pathophysiology, challenges, and perspectives;Rana;Circ. Res.,2019

3. Roles of TGF-beta Superfamily Proteins in Extravillous Trophoblast Invasion;Li;Trends. Endocrinol. Metab.,2021

4. Investigation of human trophoblast invasion in vitro;Abbas;Hum. Reprod. Update.,2020

5. Radicals, Oxidative/Nitrosative Stress and Preeclampsia;Taysi;Mini. Rev. Med. Chem.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced uterine perfusion pressure as a model for preeclampsia and fetal growth restriction in murine: a systematic review and meta-analysis;American Journal of Physiology-Heart and Circulatory Physiology;2024-07-01

2. TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer;Cancer and Metastasis Reviews;2024-03-07

3. Unraveling the molecular mechanisms driving enhanced invasion capability of extravillous trophoblast cells: a comprehensive review;Journal of Assisted Reproduction and Genetics;2024-02-05

4. Mesenchymal stem cell‐derived exosomes in preeclampsia: A next‐generation therapeutic tool;Cell Biochemistry and Function;2024-01

5. Corrigendum to “Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia” [Int. Immunopharmacol. 115 (2023) 109732];International Immunopharmacology;2023-07